Host genetic variation guides hepacivirus clearance, chronicity, and liver fibrosis in mice.
Hepatology.
2024 Jan 1;79(1):183-197. doi: 10.1097/HEP.0000000000000547. Epub 2023 Aug 7. PubMed PMID:
37540195; PubMed Central PMCID:
PMC10718216.
Programmable antivirals targeting critical conserved viral RNA secondary structures from influenza A virus and SARS-CoV-2.
Nat Med.
2022 Sep;28(9):1944-1955. doi: 10.1038/s41591-022-01908-x. Epub 2022 Aug 18. PubMed PMID:
35982307; PubMed Central PMCID:
PMC10132811.
Infectious Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Virus in Symptomatic Coronavirus Disease 2019 (COVID-19) Outpatients: Host, Disease, and Viral Correlates.
Clin Infect Dis.
2022 Aug 24;75(1):e1028-e1036. doi: 10.1093/cid/ciab968. PubMed PMID:
35022711; PubMed Central PMCID:
PMC9402664.
Mutations in the SARS-CoV-2 RNA-dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms.
Sci Transl Med.
2022 Aug 3;14(656):eabo0718. doi: 10.1126/scitranslmed.abo0718. Epub 2022 Aug 3. PubMed PMID:
35482820; PubMed Central PMCID:
PMC9097878.
Therapeutic treatment with an oral prodrug of the remdesivir parental nucleoside is protective against SARS-CoV-2 pathogenesis in mice.
Sci Transl Med.
2022 May 4;14(643):eabm3410. doi: 10.1126/scitranslmed.abm3410. Epub 2022 May 4. PubMed PMID:
35315683; PubMed Central PMCID:
PMC8995034.
Facile discovery of surrogate cytokine agonists.
Cell.
2022 Apr 14;185(8):1414-1430.e19. doi: 10.1016/j.cell.2022.02.025. Epub 2022 Mar 23. PubMed PMID:
35325595; PubMed Central PMCID:
PMC9021867.
A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus.
Sci Transl Med.
2022 Jan 19;14(628):eabl7430. doi: 10.1126/scitranslmed.abl7430. Epub 2022 Jan 19. PubMed PMID:
34941423; PubMed Central PMCID:
PMC10763622.
Global public health security and justice for vaccines and therapeutics in the COVID-19 pandemic.
EClinicalMedicine.
2021 Sep;39:101053. doi: 10.1016/j.eclinm.2021.101053. Epub 2021 Aug 3. Review. PubMed PMID:
34368661; PubMed Central PMCID:
PMC8330385.
β-d-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells.
J Infect Dis.
2021 Aug 2;224(3):415-419. doi: 10.1093/infdis/jiab247. PubMed PMID:
33961695; PubMed Central PMCID:
PMC8136050.
Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in mice.
Cell Rep.
2021 Jul 27;36(4):109450. doi: 10.1016/j.celrep.2021.109450. Epub 2021 Jul 10. PubMed PMID:
34289384; PubMed Central PMCID:
PMC8270748.
Operation Warp Speed: implications for global vaccine security.
Lancet Glob Health.
2021 Jul;9(7):e1017-e1021. doi: 10.1016/S2214-109X(21)00140-6. Epub 2021 Mar 26. Review. PubMed PMID:
33780663; PubMed Central PMCID:
PMC7997645.
Beyond the jab: A need for global coordination of pharmacovigilance for COVID-19 vaccine deployment.
EClinicalMedicine.
2021 Jun;36:100925. doi: 10.1016/j.eclinm.2021.100925. Epub 2021 Jun 3. PubMed PMID:
34099998; PubMed Central PMCID:
PMC8173024.
Urgent needs to accelerate the race for COVID-19 therapeutics.
EClinicalMedicine.
2021 Jun;36:100911. doi: 10.1016/j.eclinm.2021.100911. eCollection 2021 Jun. PubMed PMID:
34036254; PubMed Central PMCID:
PMC8141354.
Hypergraph models of biological networks to identify genes critical to pathogenic viral response.
BMC Bioinformatics.
2021 May 29;22(1):287. doi: 10.1186/s12859-021-04197-2. PubMed PMID:
34051754; PubMed Central PMCID:
PMC8164482.
Critical ACE2 Determinants of SARS-CoV-2 and Group 2B Coronavirus Infection and Replication.
mBio.
2021 Mar 16;12(2). doi: 10.1128/mBio.03149-20. PubMed PMID:
33727353; PubMed Central PMCID:
PMC8092278.
Correcting COVID-19 vaccine misinformation: Lancet Commission on COVID-19 Vaccines and Therapeutics Task Force Members.
EClinicalMedicine.
2021 Mar;33:100780. doi: 10.1016/j.eclinm.2021.100780. Epub 2021 Mar 6. PubMed PMID:
33718854; PubMed Central PMCID:
PMC7935671.
Primer ID Next-Generation Sequencing for the Analysis of a Broad Spectrum Antiviral Induced Transition Mutations and Errors Rates in a Coronavirus Genome.
Bio Protoc.
2021 Mar 5;11(5):e3938. doi: 10.21769/BioProtoc.3938. eCollection 2021 Mar 5. PubMed PMID:
33796612; PubMed Central PMCID:
PMC8005877.
Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo.
J Exp Med.
2021 Mar 1;218(3). doi: 10.1084/jem.20201993. PubMed PMID:
33211088; PubMed Central PMCID:
PMC7673958.
Urgent needs of low-income and middle-income countries for COVID-19 vaccines and therapeutics.
Lancet.
2021 Feb 13;397(10274):562-564. doi: 10.1016/S0140-6736(21)00242-7. Epub 2021 Jan 28. PubMed PMID:
33516284; PubMed Central PMCID:
PMC7906712.
A mechanism-based pharmacokinetic model of remdesivir leveraging interspecies scaling to simulate COVID-19 treatment in humans.
CPT Pharmacometrics Syst Pharmacol.
2021 Feb;10(2):89-99. doi: 10.1002/psp4.12584. Epub 2021 Jan 25. PubMed PMID:
33296558; PubMed Central PMCID:
PMC7894405.
Genomic RNA Elements Drive Phase Separation of the SARS-CoV-2 Nucleocapsid.
Mol Cell.
2020 Dec 17;80(6):1078-1091.e6. doi: 10.1016/j.molcel.2020.11.041. Epub 2020 Nov 27. PubMed PMID:
33290746; PubMed Central PMCID:
PMC7691212.
Human Lung Stem Cell-Based Alveolospheres Provide Insights into SARS-CoV-2-Mediated Interferon Responses and Pneumocyte Dysfunction.
Cell Stem Cell.
2020 Dec 3;27(6):890-904.e8. doi: 10.1016/j.stem.2020.10.005. Epub 2020 Oct 21. PubMed PMID:
33128895; PubMed Central PMCID:
PMC7577733.
Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2.
Cell.
2020 Nov 25;183(5):1367-1382.e17. doi: 10.1016/j.cell.2020.10.043. Epub 2020 Oct 31. PubMed PMID:
33160446; PubMed Central PMCID:
PMC7604136.
A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice.
Cell.
2020 Nov 12;183(4):1070-1085.e12. doi: 10.1016/j.cell.2020.09.050. Epub 2020 Sep 23. PubMed PMID:
33031744; PubMed Central PMCID:
PMC7510428.
High Potency of a Bivalent Human V(H) Domain in SARS-CoV-2 Animal Models.
Cell.
2020 Oct 15;183(2):429-441.e16. doi: 10.1016/j.cell.2020.09.007. Epub 2020 Sep 4. PubMed PMID:
32941803; PubMed Central PMCID:
PMC7473018.
A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures.
Nature.
2020 Oct;586(7830):560-566. doi: 10.1038/s41586-020-2708-8. Epub 2020 Aug 27. PubMed PMID:
32854108; PubMed Central PMCID:
PMC8034761.
DNA vaccine protection against SARS-CoV-2 in rhesus macaques.
Science.
2020 Aug 14;369(6505):806-811. doi: 10.1126/science.abc6284. Epub 2020 May 20. PubMed PMID:
32434945; PubMed Central PMCID:
PMC7243363.
SARS-CoV-2 infection protects against rechallenge in rhesus macaques.
Science.
2020 Aug 14;369(6505):812-817. doi: 10.1126/science.abc4776. Epub 2020 May 20. PubMed PMID:
32434946; PubMed Central PMCID:
PMC7243369.
Transmission of viral pathogens in a social network of university students: the eX-FLU study.
Epidemiol Infect.
2020 Aug 14;148:e267. doi: 10.1017/S0950268820001806. PubMed PMID:
32792023; PubMed Central PMCID:
PMC7689784.
Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice.
Cell Rep.
2020 Jul 21;32(3):107940. doi: 10.1016/j.celrep.2020.107940. Epub 2020 Jul 7. PubMed PMID:
32668216; PubMed Central PMCID:
PMC7340027.
COVID-19: from epidemiology to treatment.
Eur Heart J.
2020 Jun 7;41(22):2092-2112. doi: 10.1093/eurheartj/ehaa462. PubMed PMID:
32511724; PubMed Central PMCID:
PMC7279517.
The continued epidemic threat of SARS-CoV-2 and implications for the future of global public health.
Curr Opin Virol.
2020 Feb;40:37-40. doi: 10.1016/j.coviro.2020.05.010. Epub 2020 Jun 4. Review. PubMed PMID:
32569751; PubMed Central PMCID:
PMC7269927.
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice.
Sci Transl Med.
2020 Apr 29;12(541). doi: 10.1126/scitranslmed.abb5883. Epub 2020 Apr 6. PubMed PMID:
32253226; PubMed Central PMCID:
PMC7164393.
The Current and Future State of Vaccines, Antivirals and Gene Therapies Against Emerging Coronaviruses.
Front Microbiol.
2020;11:658. doi: 10.3389/fmicb.2020.00658. eCollection 2020. Review. PubMed PMID:
32390971; PubMed Central PMCID:
PMC7193113.
Virus-Host Interactions Between Nonsecretors and Human Norovirus.
Cell Mol Gastroenterol Hepatol.
2020;10(2):245-267. doi: 10.1016/j.jcmgh.2020.03.006. Epub 2020 Apr 11. PubMed PMID:
32289501; PubMed Central PMCID:
PMC7301201.
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV.
Nat Commun.
2020 Jan 10;11(1):222. doi: 10.1038/s41467-019-13940-6. PubMed PMID:
31924756; PubMed Central PMCID:
PMC6954302.
Small-Molecule Antiviral β-d-N(4)-Hydroxycytidine Inhibits a Proofreading-Intact Coronavirus with a High Genetic Barrier to Resistance.
J Virol.
2019 Dec 15;93(24). doi: 10.1128/JVI.01348-19. Print 2019 Dec 15. PubMed PMID:
31578288; PubMed Central PMCID:
PMC6880162.
Increasing the translation of mouse models of MERS coronavirus pathogenesis through kinetic hematological analysis.
PLoS One.
2019;14(7):e0220126. doi: 10.1371/journal.pone.0220126. eCollection 2019. PubMed PMID:
31339932; PubMed Central PMCID:
PMC6655769.
Nucleoside analogues for the treatment of coronavirus infections.
Curr Opin Virol.
2019 Apr;35:57-62. doi: 10.1016/j.coviro.2019.04.002. Epub 2019 May 21. Review. PubMed PMID:
31125806; PubMed Central PMCID:
PMC7102703.
Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis.
mBio.
2018 Oct 9;9(5). doi: 10.1128/mBio.01753-18. PubMed PMID:
30301856; PubMed Central PMCID:
PMC6178621.
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease.
mBio.
2018 Mar 6;9(2). doi: 10.1128/mBio.00221-18. PubMed PMID:
29511076; PubMed Central PMCID:
PMC5844999.
Is regulation preventing the development of therapeutics that may prevent future coronavirus pandemics?.
Future Virol.
2018 Mar;13(3):143-146. doi: 10.2217/fvl-2017-0143. Epub 2018 Feb 21. PubMed PMID:
30546388; PubMed Central PMCID:
PMC6289267.
Conformational Occlusion of Blockade Antibody Epitopes, a Novel Mechanism of GII.4 Human Norovirus Immune Evasion.
mSphere.
2018 Jan-Feb;3(1). doi: 10.1128/mSphere.00518-17. eCollection 2018 Jan-Feb. PubMed PMID:
29435493; PubMed Central PMCID:
PMC5806210.
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses.
Sci Transl Med.
2017 Jun 28;9(396). doi: 10.1126/scitranslmed.aal3653. PubMed PMID:
28659436; PubMed Central PMCID:
PMC5567817.
SARS-like WIV1-CoV poised for human emergence.
Proc Natl Acad Sci U S A.
2016 Mar 15;113(11):3048-53. doi: 10.1073/pnas.1517719113. Epub 2016 Mar 14. PubMed PMID:
26976607; PubMed Central PMCID:
PMC4801244.
Multi-Modal Imaging with a Toolbox of Influenza A Reporter Viruses.
Viruses.
2015 Oct 13;7(10):5319-27. doi: 10.3390/v7102873. PubMed PMID:
26473913; PubMed Central PMCID:
PMC4632381.
The Role of Phosphodiesterase 12 (PDE12) as a Negative Regulator of the Innate Immune Response and the Discovery of Antiviral Inhibitors.
J Biol Chem.
2015 Aug 7;290(32):19681-96. doi: 10.1074/jbc.M115.653113. Epub 2015 Jun 8. PubMed PMID:
26055709; PubMed Central PMCID:
PMC4528132.
New Methods in Tissue Engineering: Improved Models for Viral Infection.
Annu Rev Virol.
2014 Nov;1:475-499. doi: 10.1146/annurev-virology-031413-085437. PubMed PMID:
25893203; PubMed Central PMCID:
PMC4398347.
Interferon lambda alleles predict innate antiviral immune responses and hepatitis C virus permissiveness.
Cell Host Microbe.
2014 Feb 12;15(2):190-202. doi: 10.1016/j.chom.2014.01.007. PubMed PMID:
24528865; PubMed Central PMCID:
PMC4104123.
Single cell analysis of HCV-infected patient hepatocytes: the science is no longer science fiction.
Gastroenterology.
2013 Dec;145(6):1199-202. doi: 10.1053/j.gastro.2013.10.035. Epub 2013 Oct 29. PubMed PMID:
24176873; PubMed Central PMCID:
PMC3885988.
What would you like to do?